This brand name is authorized in Nigeria
The drug ARTELIFE contains one active pharmaceutical ingredient (API):
|
1
α-β Arteether
UNII WN2E3JXJ67 - .ALPHA./.BETA. ARTEETHERS
|
|
Artemisinin is used in the treatment of malaria due to species Plasmodium. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| P01BE | Artemisinin and derivatives | P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: NG | Registered Drug Product Database | Identifier(s): B4-4774 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
